Blog

Practical guidance on SBIR, STTR, and other non-dilutive funding from the BW&CO team. Read about agency programs, proposal strategy, compliance after award, and new funding opportunities for deep-tech, biotech, medtech, and defense founders.

Josiah Wegner Josiah Wegner

The Best SBIR/STTR Consulting Firms (2026 Guide)

Most SBIR consulting firms focus on training, execution, or past experience, but funding outcomes in 2026 increasingly depend on strategy and positioning. The top firms differ in how they approach proposal development, commercialization, and alignment with agency priorities. Choosing the right partner means understanding these differences and selecting a firm that fits your stage, goals, and competitiveness within the program.

Read More
Josiah Wegner Josiah Wegner

Has Your SBIR Consultant Adapted to What NIH SBIR Funding Has Become in 2026?

Most SBIR firms rely on experience or execution, but NIH funding decisions in 2026 go beyond what’s written. Winning proposals align with real-time IC priorities through AI-driven insight, human expertise, and direct Program Officer engagement. The teams that succeed aren’t guessing—they validate fit with NIH before submission and position accordingly.

Read More
Josiah Wegner Josiah Wegner

We’re Guessing What the Government Actually Wants

Federal solicitations, especially DoD topics, tell you the rules but they rarely reveal the full picture of what the government actually wants. Winning proposals go beyond compliance by interpreting mission drivers, funding realities, and unstated operational needs through informed conversations, funding history, and strategic positioning. The teams that succeed are not guessing blindly; they are reading between the lines and aligning their solution to the problem behind the problem.

Read More
Josiah Wegner Josiah Wegner

Our Technology Is Strong but Reviewers Don’t Get It

Founders often believe their technology is strong and reviewers simply “didn’t get it,” but in non-dilutive funding, clarity, alignment, and mission fit matter just as much as innovation. This article breaks down why strong science alone isn’t enough and how reframing your proposal through the reviewer’s lens can dramatically improve your chances of winning awards.

Read More
Josiah Wegner Josiah Wegner

Stop Wasting Time on Low-Probability Grant Opportunities

For many founders, researchers, and small business teams, grant funding is supposed to be a catalyst, not a distraction. Yet too often, teams find themselves pouring months of effort into applications that were never realistically competitive in the first place. Here’s how to prioritize which grants to apply for.

Read More
Josiah Wegner Josiah Wegner

Understanding NIH Impact Scores

As NIH review results are released, many applicants are asking the same question: how should I interpret my outcome, and what does it mean for funding? Recent NIH review cycles have introduced clearer distinctions in how applications are categorized, making it especially important to understand what your result actually signals.

Read More